>Introduction to Pharmacoepidemiology (November)

  • Venue: Solent Hotel, Whiteley, Fareham
  • Date: 31 Oct - 01 Nov 2018
  • Cost per delegate:
    • Or £775 + VAT academic

      (academic units, public sector organisations, registered charities)

    • Or £1300 + VAT pmst


    • Or £1190 + VAT standard

      (standard registration)

Book your place

Download course programme


PharmacoepidemiologyPharmacoepidemiology is a key discipline for understanding the safety of medicines, it has made important contributions to our understanding of drug safety. It is also being increasingly recognised as a practical tool for supporting risk management and planning safety activities at the time medicines are authorised. Expertise in pharmacoepidemiology is now a must for any research based pharmaceutical company. Our Introduction to Pharmacoepidemiology course is aimed at introducing delegates to the core concepts of this scientific discipline. Attendance at this course can be used as part of the training required for the Drug Safety Surveillance module of the Pharmaceutical Medicine Specialty Training (PMST).

Here are a few more reasons to attend the course:

     – Key discipline for understanding the safety of medicines
     – Mix of presentations and interactive workshops
     – Delegates’ course rate: 4.4 out of 5


This course is aimed at:
• Pharmaceutical industry personnel from areas including pharmacovigilance, clinical research, medical affairs,medical writing, regulatory affairs and medical information
• Pharmaceutical physicians completing the Drug Safety Surveillance module of Pharmaceutical Medicine Specialty Training (PMST)
• Staff from regulatory authorities
• NHS, NHS & R&D and other research organisation, doctors, nurses, medical information pharmacists, pharmaceutical advisors or other professions allied to medicine

Please click here to view the course programme

Please note that the course dates and programme may be subject to change.

The course is recognised by PharmaTrain.

“Workshops and interactive sessions were very well organised. The workshop subjects were very helpful and the discussion with the facilitators was brilliant!” Introduction to Pharmacoepidemiology Delegate Apr 18

“Excellent lectures! Very comprehensive!” Introduction to Pharmacoepidemiology Delegate Nov 2017

“Well organised as always! Very informative and a good introduction to the field. Lots of content covered!!” Introduction to Pharmacoepidemiology Delegate Nov 2017

“Good introduction to the whole concept of pharmacoepidemiology.” Introduction to Pharmacoepidemiology Delegate April 2017

“Great course! Very informative and interesting.” Introduction to Pharmacoepidemiology Delegate April 2016


  • To provide students with a grounding in, and analysis of, core principles of epidemiology
  • To show how epidemiological technique are applied to pharmacoepidemiological studies
  • To review the development of pharmacoepidemiology as a science as its place in modern medicine
  • To review modern methods and data sources used in pharmacoepidemiology
  • To develop a critical understanding of the types, assessment and appropriate application of port-marketing drug safety data and their contribution to the marketing, regulatory compliance, safety monitoring and risk management associated with pharmaceuticals

Programme features:

  • History and basic principles of epidemiology and pharmacoepidemiology
  • Pharmacoepidemiology as a modern scientific discipline
  • Analysis and interpretation of pharmacoepidemiological data
  • Use of pharmacoepidemiology in the detection and investigation of safety signals
  • Pharmacoepidemiology and risk management planning

On successful completion of this course delegates should be able to:

  • Critically analyse the relationship between epidemiology and pharmacoepidemiology
  • Define and justify the elements of an ideal database to be used to conduct a pharmacoepidemiological study of a drug safety issue
  • Differentiate the important features of pharmacoepidemiological investigations that allow comparisons within and between pharmacoepidemiological data resources
  • Critically apply common techniques of analysis in the interpretation of pharmacoepidemiological data for pharmacovigilance purposes